Cantor Fitzgerald analyst Prakhar Agrawal reiterates Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Neutral.
Cantor Fitzgerald Reiterates Neutral on Madrigal Pharmaceuticals
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.